Physician profile
Adam Cohen
NPI 1942296140
$185,019.09
in general payments reported to CMS, 2019-2025
26 companies · $26K in 2025
The $26K reported for 2025 was more than what 97% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $68K · 2020: $20K · 2021: $17K · 2022: $20K · 2023: $17K · 2024: $17K · 2025: $26K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $53K · Food and Beverage: $4,394 · Travel and Lodging: $3,447.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $52,504.00 |
| Food and Beverage | $4,393.57 |
| Travel and Lodging | $3,446.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $161,025.07 | 2019-2025 | Repatha, Repatha |
| Sanofi-Aventis U.S. LLC | $18,862.84 | 2019-2023 | |
| Janssen Pharmaceuticals, INC | $1,034.93 | 2019-2024 | Xarelto |
| Regeneron Healthcare Solutions, INC. | $970.00 | 2019 | |
| Pfizer INC. | $509.19 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $455.01 | 2019-2025 | Camzyos, Eliquis |
| Astrazeneca Pharmaceuticals LP | $437.27 | 2019-2024 | Farxiga |
| Novartis Pharmaceuticals Corporation | $346.37 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $259.84 | 2019-2025 | Jardiance |
| Boston Scientific Corporation | $207.21 | 2019-2025 | Watchman Access System |
| Janssen Biotech, INC. | $162.85 | 2020-2023 | Tecvayli, Darzalex |
| Amarin Pharma, INC. | $125.65 | 2019-2021 | |
| Esperion Therapeutics, INC. | $104.76 | 2024-2025 | Nexletol |
| Kiniksa Pharmaceuticals, LTD. | $102.56 | 2022-2023 | Arcalyst |
| Alnylam Pharmaceuticals INC. | $86.87 | 2025 | Onpattro |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $83.95 | 2024-2025 | Verquvo, Capvaxive |
| Regeneron Pharmaceuticals, INC. | $50.41 | 2019 | |
| Inspire Medical Systems, INC. | $35.60 | 2023-2024 | Inspire |
| Kiniksa Pharmaceuticals International, Plc | $34.85 | 2024 | Arcalyst |
| Novo Nordisk INC | $23.19 | 2025 | Wegovy |
| Endotronix, INC. | $22.53 | 2024 | Cordella Pulomonary Artery Pressure Sensor |
| Teleflex LLC | $22.20 | 2025 | Barrigel |
| Bayer Healthcare Pharmaceuticals INC. | $16.38 | 2025 | |
| Edwards Lifesciences Corporation | $15.90 | 2019 | |
| Gilead Sciences, INC. | $12.87 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $10.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Cohen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.